Dennis Podlesak, Director at Syndax Pharmaceuticals Inc (SNDX), sold 90,790 shares at $23.43 ($2.2M) on 2022-09-16, disclosed to the SEC on 2022-09-16.
Open-market sale of $2.2M SNDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.20 | 66,840 | $1.6M | 74.2% |
| 2 | $23.43 | 5,419 | $127K | 5.8% |
| 3 | $23.43 | 5,419 | $127K | 5.8% |
| 4 | $23.43 | 6,556 | $154K | 7.1% |
| 5 | $23.43 | 6,556 | $154K | 7.1% |
| Total | $24.00 avg | 90,790 |
| $2.2M |
| 100% |
| Filing → |
| AVNR | BUY | 2006-06-02 | $10K | — | Filing → |